X

FIERCELY FOCUSED
ON PATIENTS

CLINICAL TRIAL INFORMATION AND RECRUITMENT

TG Therapeutics is committed to the development of innovative medicines that deliver novel treatments for patients suffering from B-cell diseases. An integral part of achieving this goal is the conduct of robust and efficient clinical trials at the highest standards of quality attainable.

Information on all of TG Therapeutics’ ongoing clinical trials, including information for healthcare providers and patients interested in participating in any ongoing clinical trials, can be found at www.ClinicalTrials.gov.

OUR PHASE 3 PROGRAMS IN MULTIPLE SCLEROSIS

PHASE 3b ENHANCE TRIAL

Recruiting Patients

PHASE 3 ULTIMATE I & II TRIALS

Ongoing, but no longer recruiting

OUR POST-MARKETING PROGRAM

PROVIDE LACTATION STUDY

Recruiting Patients
Scroll to Top

You are now leaving TGTherapeutics.com, a website wholly owned and operated by TG Therapeutics, Inc. This link will take you to a website to which this Privacy Policy does not apply. TG Therapeutics, Inc., does not endorse or influence the content of websites that are not owned or operated by TG Therapeutics, Inc.

You are now leaving TGTherapeutics.com, a website wholly owned and operated by TG Therapeutics, Inc. This link will take you to a website to which this Privacy Policy does not apply. TG Therapeutics, Inc., does not endorse or influence the content of websites that are not owned or operated by TG Therapeutics, Inc.

You are now leaving TGTherapeutics.com, a website wholly owned and operated by TG Therapeutics, Inc. This link will take you to a website to which this Privacy Policy does not apply. TG Therapeutics, Inc., does not endorse or influence the content of websites that are not owned or operated by TG Therapeutics, Inc.